Company profile: Quellis Bio
1.1 - Company Overview
Company description
- Provider of next-generation antibody therapies aimed at improving outcomes for patients with serious rare diseases, focusing on discovering best-in-class new molecules to address underserved treatment needs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quellis Bio
Imegen
HQ: Spain
Website
- Description: Provider of biomedical services and products for genetic analysis, offering diagnostic, prognostic, and preventive genetic services to improve health and quality of life, with the aim of being a worldwide reference in human genetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imegen company profile →
Soin Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical drug development focused on new medications for rare, orphan diseases, including a novel formulation of low-dose naltrexone to treat CRPS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soin Therapeutics company profile →
Aceragen
HQ: United States
Website
- Description: Provider of therapeutic treatments for rare and ultra-rare diseases, developing investigational products including ACG-801, a recombinant human acid ceramidase enzyme replacement therapy for Farber disease, and ACG-701, an oral sodium fusidate antibiotic for melioidosis and for acute pulmonary exacerbations in cystic fibrosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aceragen company profile →
Audentes Therapeutics
HQ: United States
Website
- Description: Provider of gene therapy research and development for rare muscle diseases, serving as the Gene Therapy Center of Excellence with divisions in technical operations, medical and development, and future commercialization of gene therapy programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Audentes Therapeutics company profile →
Aro Biotherapeutics
HQ: United States
Website
- Description: Provider of tissue-targeted genetic medicines leveraging Centyrins, a proprietary small engineered protein platform, for targeted delivery to specific cells. Develops oligonucleotide-based therapeutics that modulate gene expression, including ABX1100, a Centyrin-siRNA conjugate targeting CD71 and Gys1 mRNA for Pompe disease to reduce muscle glycogen.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aro Biotherapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quellis Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quellis Bio
2.2 - Growth funds investing in similar companies to Quellis Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quellis Bio
4.2 - Public trading comparable groups for Quellis Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →